skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Characterization of antralin: an endogenous protein inhibitor of radioligand binding to (/sup 3/H)RO 5-4864 and (/sup 3/H)nitrendipine binding sites

Conference · · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
OSTI ID:5462941

The presence of substances isolated from rat antral stomach that inhibit the binding of (/sup 3/H)Ro 5-4864 (4'-chlorodiazepam) to peripheral-type benzodiazepine receptors (PBR), but do not affect the binding of (/sup 3/H)diazepam to brain-type benzodiazepine receptors have been described. These substances, now obtained by isolation on Sep-Pak C/sub 18/ cartridges, also had no effect on (/sup 3/)PK 11195 binding which labels an antagonist site associated with PBR. Neither was any significant inhibition of (/sup 3/H)Ro 15-1788, (/sup 3/H)..beta..CCM, or (/sup 3/H)dihydroalprenolol binding observed. However, the Sep-Pak eluates were found to produce a concentration-dependent inhibition of (/sup 3/H)nitrendipine binding equivalent to that seen with (/sup 3/H)Ro 5-4864. This material, termed antralin, reduced the apparent K/sub d/ of both radioligands without significantly affecting B/sub max/. Its activity was destroyed by both heat treatment and pronase, and partially reduced by trypsin. Furthermore, its activity was enhanced by Ca/sup + +/ (0.1 mM). Antralin levels were unevenly distributed in rat tissues. These findings suggest that antralin is a protein that may regulate both PBR and dihydropyridine Ca/sup + +/-channel antagonist binding sites in vivo.

Research Organization:
NIADDK, Bethesda, MD
OSTI ID:
5462941
Report Number(s):
CONF-8604222-; TRN: 86-028361
Journal Information:
Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States), Vol. 45:3; Conference: 70. annual meeting of the Federation of American Society for Experimental Biology, St. Louis, MO, USA, 13 Apr 1986
Country of Publication:
United States
Language:
English